Medical Study Reveals Why Older Adults Choose Cannabis Edibles
A recent medical study examined cannabis edible use among older adults, revealing therapeutic rather than recreational motivations. Older adults cannabis edibles consumption focuses on pain management and mental health symptom relief when traditional…
Cannabis Schedule III Rescheduling Impact on Medical Research and Patients
The potential rescheduling of cannabis from Schedule I to Schedule III represents a significant regulatory shift that could reduce research barriers and accelerate clinical investigation. Cannabis schedule III rescheduling would lower DEA registration…
FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
Understanding Your Endocannabinoid System Through Scientific Research
Understanding the endocannabinoid system requires examining peer-reviewed scientific research rather than dismissing cannabis medicine entirely. Dr. Benjamin Caplan leads evidence-based cannabis care at CED Clinic, focusing on how endocannabinoid system…
Medical Cannabis Education Has Not Kept Pace With Clinical Reality
Medical cannabis provider knowledge may be far weaker than many clinicians believe. A survey of 879 U.S. healthcare professionals found large gaps between self-rated confidence and objective cannabis knowledge. The findings raise important questions…
Research study on Maltese cannabis users (Still open for participants) : r/malta – Reddit
Research on maltese cannabis users research study provides crucial epidemiological data following Malta's recent legalization. This clinical analysis examines the value of Mediterranean cannabis research for evidence-based practice. Understanding usage…
Cannabis & Psychosis Study
This cannabis psychosis study examined whether cannabis and tobacco co-use predicted psychosis conversion in people already considered clinically high risk. The paper identified a concerning subgroup signal involving heavy cannabis use and light tobacco…
President Biden Signs Historic Cannabis Research Bill – Ganjapreneur
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Cannabis ResearchPolicyResearchHempCBDTHCSafety Why This Matters I don't see the article summary provided in your…
A Placebo-Controlled Cannabis Trial for Migraine Just Produced Real Results
A new randomized placebo-controlled trial found vaporized THC-plus-CBD cannabis improved acute migraine symptoms compared with placebo. The study represents one of the strongest migraine cannabis trials published to date. Dr. Caplan explains why…
What UK Biobank Data Suggests About Cannabis, BMI, Diabetes, and Hypertension
This cannabis metabolic health study analyzed 91,002 UK Biobank participants to explore links between cannabis use, diabetes, hypertension, and obesity risk. Researchers found lower rates of several metabolic conditions among cannabis users, but BMI…